Hard-hit cannabinoid firms in the US and Canada are reassessing their market strategies, restructuring, and downsizing – in some cases with significant job cuts – as the market remains volatile
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields